Are you Dr. Miyamoto?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 4 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
# 320
Rochester, NY 14642Phone+1 585-275-8748Fax+1 585-273-3637- Is this information wrong?
Summary
- Dr. Hiroshi Miyamoto, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Maryland. He is affiliated with Strong Memorial Hospital of the University of Rochester and F. F. Thompson Hospital.
Education & Training
- Johns Hopkins University School of MedicineSelective Pathology, 2008 - 2009
- Yokohama City University School of MedicineClass of 1988
Certifications & Licensure
- NY State Medical License 2008 - 2026
- MD State Medical License 2013 - 2017
- American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- A simple risk stratification model for prostate cancer using histopathologic findings of radical prostatectomy.Remi Semba, Katsunori Uchida, Yoshihumi Hirokawa, Taizo Shiraishi, Takehisa Onishi, Takeshi Sasaki, Takahiro Inoue, Masatoshi Watanabe, Hiroshi Miyamoto> ;American Journal of Clinical Pathology. 2024 May 5
- The Role of Adipocytokines and their Receptors in Prostate Cancer: Adiponectin May Protect Against Progression.Eiji Kashiwagi, Takashi Kawahara, Fumio Kinoshita, Masaki Shiota, Junichi Inokuchi, Masatoshi Eto, Hiroshi Miyamoto> ;Anticancer Research. 2024 Apr 1
- 1 citationsClinical significance of location of perineural cancer invasion detected on prostate needle core biopsy.Benjamin G Gertsen, Yuki Teramoto, Ying Wang, Toyonori Tsuzuki, Hiroshi Miyamoto> ;Virchows Archiv. 2024 Mar 15
- Join now to see all
Press Mentions
- Time-Dependent Efficacy of Combination of Silver-Containing Hydroxyapatite Coating and Vancomycin on Methicillin-Resistant Staphylococcus Aureus Biofilm Formation in VitroMarch 2nd, 2021
- Effects of α1-Adrenergic Receptor Antagonists on the Development and Progression of Urothelial CancerDecember 1st, 2020
- Enhanced Metastatic Potential in the MB49 Urothelial Carcinoma ModelMay 15th, 2019
Other Languages
- Japanese
Hospital Affiliations
- Strong Memorial Hospital of the University of RochesterRochester, New York
- F. F. Thompson HospitalCanandaigua, New York